|
PTPLB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62525548574877E-12 |
| Normal-vs-Stage2 |
1.7821299991283E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.861400E-01 |
| Stage1-vs-Stage3 |
2.761600E-03 |
| Stage1-vs-Stage4 |
9.616100E-03 |
| Stage2-vs-Stage3 |
1.602180E-01 |
| Stage2-vs-Stage4 |
2.054000E-01 |
| Stage3-vs-Stage4 |
9.881200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
4.363600E-03 |
| Caucasian-vs-AfricanAmerican |
1.311530E-02 |
| Caucasian-vs-Asian |
3.761200E-01 |
| AfricanAmerican-vs-Asian |
4.200000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
3.365000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.85470544372879E-11 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.4432899320127E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.475200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.308200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.744600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.983400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.295940E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.600300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.61055999999826E-05 |
| Normal-vs-Grade 2 |
1.62592161956354E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 1-vs-Grade 2 |
2.882400E-01 |
| Grade 1-vs-Grade 3 |
6.500100E-02 |
| Grade 1-vs-Grade 4 |
2.696100E-03 |
| Grade 2-vs-Grade 3 |
3.196100E-02 |
| Grade 2-vs-Grade 4 |
5.94090000000103E-05 |
| Grade 3-vs-Grade 4 |
1.207760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.32587340685131E-15 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
5.791700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62481139653892E-12 |
| Normal-vs-N1 |
2.45590000003126E-06 |
| N0-vs-N1 |
6.784400E-01 |
|
|
